Landscapes / Targets

complement C5

11 drugs act on complement C5, in 36 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs11

DrugHow it worksCompanyStageNext dateDetails
Complement inhibitor
Approved 7 Dec 2026soonPhase 3 trial completes
Monoclonal antibody
Approved 15 Dec 2026soonPhase 3 trial completes
Monoclonal antibody
Roche · Public ROG.SW
Approved 18 Apr 2027Phase 3 trial completes
Complement inhibitor
Approved 12 May 2027Phase 2/3 trial completes
Complement inhibitor
Approved 25 Jun 2027Phase 4 trial completes
Complement inhibitor
Regeneron · Public REGN
Approved 31 Jul 2028Phase 3 trial completes
Monoclonal antibody
Approved in the EU Jul 2028Phase 2 trial completes
Small interfering RNA
Regeneron · Public REGN
Phase 3 31 Jul 2028Phase 3 trial completes
—
Phase 2 30 Dec 2027Phase 2 trial completes
—
Phase 2 Dec 2028Phase 2 trial completes
—
Phase 1 30 Sep 2027Phase 1 trial completes

About this list

Checked
11 of 11 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Complement C5

Following is part of Solo: you see every change to Complement C5 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in